Social stigmatization in Turkish patients with chronic hepatitis B and C

Basit Öğe Kaydı
dc.authoridekmen, nergiz/0000-0002-7921-3169
dc.authoridCan, Hatice/0000-0002-6054-9244;
dc.authorwosidCAN, GÜRAY/AAA-3274-2020
dc.authorwosidekmen, nergiz/AAO-8196-2021
dc.authorwosidAkyol, Taner/IWE-4470-2023
dc.authorwosidCan, Hatice/ABI-7678-2020
dc.authorwosidkasapoğlu, benan/AAZ-9381-2021
dc.contributor.authorYozgat, Ahmet
dc.contributor.authorCan, Guray
dc.contributor.authorCan, Hatice
dc.contributor.authorEkmen, Nergiz
dc.contributor.authorAkyol, Taner
dc.contributor.authorKasapoglu, Benan
dc.contributor.authorKekilli, Murat
dc.date.accessioned2024-08-04T20:49:05Z
dc.date.available2024-08-04T20:49:05Z
dc.date.issued2021
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBackground and aim: Viral hepatitis is the most important cause of chronic hepatitis worldwide. Stigmatization is defined as a feeling of rejection and isolation of patients by society due to illness. There are no studies on chronic viral hepatitis in the literature in English, which has its own religious and socio-cultural structure. In our study, we aimed to investigate the presence of social stigmatism and psychosocial effects on patients with different stages of chronic viral hepatitis B and C. Methods: Forty-five patients with chronic hepatitis C and 114 patients with chronic hepatitis B were enrolled in the study. Berger's scale was used for stigmatization, composed of 40 four-point Likert items that have four subscales: personalized stigma, disclosure, negative self-image, and public attitude. Stigma score ranges between one and four. Stigma is accepted as present if the overall score is above two. Results: Overall the mean stigma scores were 1.97 +/- 0.58 and 2.14 +/- 0.57 for chronic hepatitis B and C, respectively. There was stigma in 47.4% of the patients with chronic hepatitis B, and 60% of the patients with chronic hepatitis C. Being male was the risk factor on overall stigma, disclosure and public attitude in chronic hepatitis C. Living in an urban setting was the risk factor on negative self-image in chronic hepatitis C and on personalized stigma and disclosure in chronic hepatitis B. Conclusions: To the best of our knowledge, this is the first study that provides qualitative information about chronic hepatitis-related stigma. Stigmatization is a major problem in Turkey and worldwide. We believe that increasing the knowledge of the patients and society by teaching about the transmission routes of the disease and focusing on vaccination studies will prevent stigmatization. (C) 2020 Elsevier Espana, S.L.U. All rights reserved.en_US
dc.identifier.doi10.1016/j.gastrohep.2020.08.008
dc.identifier.endpage336en_US
dc.identifier.issn0210-5705
dc.identifier.issue5en_US
dc.identifier.pmid33213938en_US
dc.identifier.scopus2-s2.0-85096371127en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage330en_US
dc.identifier.urihttps://doi.org/10.1016/j.gastrohep.2020.08.008
dc.identifier.urihttps://hdl.handle.net/11616/99635
dc.identifier.volume44en_US
dc.identifier.wosWOS:000644704600002en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Espana Sluen_US
dc.relation.ispartofGastroenterologia Y Hepatologiaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectStigmatizationen_US
dc.subjectChronic hepatitis Ben_US
dc.subjectChronic hepatitis Cen_US
dc.titleSocial stigmatization in Turkish patients with chronic hepatitis B and Cen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu